Applied DNA Sciences Inc (NAS:APDN)
$ 3.74 0.005 (0.13%) Market Cap: 3.23 Mil Enterprise Value: 982,000.00 PE Ratio: 0 PB Ratio: 0.61 GF Score: 50/100

Q3 2019 Applied DNA Sciences Inc Earnings Call Transcript

Aug 13, 2019 / 08:30PM GMT
Release Date Price: $252.08 (+8.51%)
Operator

Good day, and welcome to the Applied DNA Sciences Fiscal Third Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Clay Shorrock, legal counsel for Applied DNA Sciences. Please go ahead.

Clay Shorrock
Applied DNA Sciences, Inc. - General Counsel

Thank you, operator, and good afternoon, everyone, and thank you for joining us for our fiscal third quarter 2019 financial results conference call. I'm Clay Shorrock of the law firm of Allen, Dyer, Doppelt, & Gilchrist, legal counsel for Applied DNA.

A copy of the company's earnings press release and accompanying PowerPoint presentation to this call are available for download under the Events and Presentations section to the Investor page of the Applied DNA website.

With me on the call today are Dr. James Hayward, Chairman and CEO; and Beth Jantzen, Chief Financial Officer.

As a reminder, please note that some of the information you will hear today during our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot